Literature DB >> 8907814

Flow cytometry in colon cancer: does flow cytometric cell cycle analysis help predict for short-term recurrence in patients with colorectal carcinoma?

C Hixon1, J Furlong, A Silbergleit.   

Abstract

The purpose of this prospective study was to determine whether tumor ploidy or S-phase fraction measurements were of prognostic value in predicting short-term recurrence for colorectal carcinoma. A total of 52 patients underwent curative resection of colorectal carcinoma. Fresh suspensions of tumor cells were used for flow cytometric analysis. Patients underwent follow-up for possible recurrence, which then was related to ploidy status, S-phase fraction measurement, adjuvant therapy received, and Dukes stage. Disease-free probability was determined using Kaplan-Meier actuarial curves for various subgroups of the study populations. Results revealed that elevated S-phase fraction (>16%) did predict for a higher probability of recurrence in those patients receiving no postoperative adjuvant treatment. Among patients receiving postoperative adjuvant therapy, however, a higher S-phase fraction predicted for a lower probability of recurrence. These data suggest that the S-phase fraction does predict for disease-free probability and also predict response to adjuvant therapy in patients with colorectal carcinoma.

Entities:  

Mesh:

Year:  1995        PMID: 8907814      PMCID: PMC2607958     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  12 in total

1.  Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas.

Authors:  K D Bauer; S T Lincoln; J M Vera-Roman; C B Wallemark; J S Chmiel; M L Madurski; T Murad; D G Scarpelli
Journal:  Lab Invest       Date:  1987-09       Impact factor: 5.662

2.  Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.

Authors:  H S Goh; J R Jass; W S Atkin; J Cuzick; J M Northover
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

3.  Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects.

Authors:  S O Emdin; R Stenling; G Roos
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

4.  DNA distribution in human colon carcinomas and its relationship to clinical behavior.

Authors:  R C Wolley; K Schreiber; L G Koss; M Karas; A Sherman
Journal:  J Natl Cancer Inst       Date:  1982-07       Impact factor: 13.506

5.  The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma.

Authors:  N A Scott; L M Rainwater; H S Wieand; L H Weiland; J H Pemberton; R W Beart; M M Lieber
Journal:  Dis Colon Rectum       Date:  1987-07       Impact factor: 4.585

6.  Flow cytometry of colorectal carcinoma with three-year follow-up.

Authors:  M R Melamed; W E Enker; P Banner; A J Janov; G Kessler; Z Darzynkiewicz
Journal:  Dis Colon Rectum       Date:  1986-03       Impact factor: 4.585

7.  Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas.

Authors:  P Quirke; M F Dixon; A D Clayden; P Durdey; J E Dyson; N S Williams; C C Bird
Journal:  J Pathol       Date:  1987-04       Impact factor: 7.996

8.  A multivariate analysis of pathologic prognostic indicators in large bowel cancer.

Authors:  T Wiggers; J W Arends; B Schutte; L Volovics; F T Bosman
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

9.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.

Authors:  L L Vindeløv; I J Christensen; N I Nissen
Journal:  Cytometry       Date:  1983-03

10.  Tumor DNA content in the prognosis of colorectal carcinoma.

Authors:  W Kokal; K Sheibani; J Terz; J R Harada
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

View more
  1 in total

1.  Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia.

Authors:  P Chatrath; I S Scott; L S Morris; R J Davies; K Bird; S L Vowler; N Coleman
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.